![](/images/graphics-bg.png)
Ginsenoside Rb1 for Myocardial IschemiaReperfusion Injury: Preclinical Evidence and Possible Mechanisms
Joint Authors
Zheng, Qun
Bao, Xiao-Yi
Zhu, Peng-Chong
Tong, Qiang
Wang, Yan
Zheng, Guo-qing
Source
Oxidative Medicine and Cellular Longevity
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-14, 14 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-12-21
Country of Publication
Egypt
No. of Pages
14
Main Subjects
Abstract EN
Ginseng is an important herbal drug that has been used worldwide for many years.
Ginsenoside Rb1 (G-Rb1), the major pharmacological extract from ginseng, possesses a variety of biological activities in the cardiovascular systems.
Here, we conducted a preclinical systematic review to investigate the efficacy of G-Rb1 for animal models of myocardial ischemia/reperfusion injury and its possible mechanisms.
Ten studies involving 211 animals were identified by searching 6 databases from inception to May 2017.
The methodological quality was assessed by using the CAMARADES 10-item checklist.
All the data were analyzed using RevMan 5.3 software.
As a result, the score of study quality ranged from 3 to 7 points.
Meta-analyses showed that G-Rb1 can significantly decrease the myocardial infarct size and cardiac enzymes (including lactate dehydrogenase, creatine kinase, and creatine kinase-MB) when compared with control group (P<0.01).
Significant decrease in cardiac troponin T and improvement in the degree of ST-segment depression were reported in one study (P<0.05).
Additionally, the possible mechanisms of G-Rb1 for myocardial infarction are antioxidant, anti-inflammatory, antiapoptosis, promoting angiogenesis and improving the circulation.
Thus, G-Rb1 is a potential cardioprotective candidate for further clinical trials of myocardial infarction.
American Psychological Association (APA)
Zheng, Qun& Bao, Xiao-Yi& Zhu, Peng-Chong& Tong, Qiang& Zheng, Guo-qing& Wang, Yan. 2017. Ginsenoside Rb1 for Myocardial IschemiaReperfusion Injury: Preclinical Evidence and Possible Mechanisms. Oxidative Medicine and Cellular Longevity،Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1195227
Modern Language Association (MLA)
Zheng, Qun…[et al.]. Ginsenoside Rb1 for Myocardial IschemiaReperfusion Injury: Preclinical Evidence and Possible Mechanisms. Oxidative Medicine and Cellular Longevity No. 2017 (2017), pp.1-14.
https://search.emarefa.net/detail/BIM-1195227
American Medical Association (AMA)
Zheng, Qun& Bao, Xiao-Yi& Zhu, Peng-Chong& Tong, Qiang& Zheng, Guo-qing& Wang, Yan. Ginsenoside Rb1 for Myocardial IschemiaReperfusion Injury: Preclinical Evidence and Possible Mechanisms. Oxidative Medicine and Cellular Longevity. 2017. Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1195227
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1195227